The eye as a window to the brain extending lifelong brain health
Nocturne specializes in products and services that allow diagnosing neurologic disorders through imaging of the eye. Nocturne’s proprietary technology (patent pending) analyses 3D images of the retina, which are obtained by optica...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
OPTIMEYEZ
Optical imaging platform for high-throughput longitudinal st...
Cerrado
BES-2012-056999
ANALISIS AVANZADO DE LAS SEÑALES DE LOS POTENCIALES EVOCADOS...
43K€
Cerrado
EQC2018-005329-P
Incorporación del primer centro español a ARI (Advanced Reni...
65K€
Cerrado
TEC2011-26066
ANALISIS AVANZADO DE LAS SEÑALES DE LOS POTENCIALES EVOCADOS...
64K€
Cerrado
PRE2020-094932
CUANTIFICACION Y CARACTERIZACION COMPUTACIONAL DE IMAGEN MUL...
99K€
Cerrado
Información proyecto Nocturne
Duración del proyecto: 6 meses
Fecha Inicio: 2019-05-06
Fecha Fin: 2019-11-30
Líder del proyecto
NOCTURNE GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Nocturne specializes in products and services that allow diagnosing neurologic disorders through imaging of the eye. Nocturne’s proprietary technology (patent pending) analyses 3D images of the retina, which are obtained by optical coherence tomography (OCT).
OCT is a noninvasive imaging technology routinely used in ophthalmology. Standard OCT devices are affordable but are by themselves of only limited value for neurologic applications.
At market entry, Nocturne offers a web service, which accepts data from standard OCT scans. The data is then analyzed with Nocturne’s technology, and a report is sent back to the customer.
With its service, Nocturne addresses customers in pharmaceutical research, academia, and clinical care. More than 10 million people suffer from neurological disorders such as multiple sclerosis, neuromyelitis optica, Parkinson’s disease, and Alzheimer, in Europe alone.
Nocturne expects that its OCT-based retinal image analysis will allow neurologists short-term diagnostic decisions, which will reduce the need for external costly MRIs. The ultimate goal is to offer specialized OCT devices in the future.